Medical devices manufacturer
Brainomix has raised €69M across 5 funding rounds from 10 investors, most recently a Series C round in Feb 2026. Based in Oxford, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-02-24 | Series C | €5.5M | Hostplus,IP Group Hostplus Innovation Fund,Modi Ventures,Parkwalk Advisors | View deal → |
| 2025-03-20 | Series C | €17M | Hostplus,Parkwalk Advisors,the Boehringer Ingelheim Venture Fund (BIVF) | View deal → |
| 2021-12-16 | Series B | €19M | Boehringer Ingelheim Venture Fund,Oxford University Innovation Fund,Parkwalk Advisors,Tencent Holdings | View deal → |
| 2018-12-07 | Other | €20M | Parkwalk Advisors Ltd | View deal → |
| 2018-02-01 | Other | €8.0M | Boehringer Ingelheim Venture Fund,Chimera Partners,Oxford University Innovation Fund,Parkwalk Advisors | View deal → |
